Dermatology Times: April 27, 2025

12345678910111213
Across
  1. 2. Strategy for choosing the right AD therapy at the right time
  2. 4. Hydrogel studied in a phase 2b trial for mild to moderate AD
  3. 7. Brand of microbiome-friendly lotion for AD
  4. 9. Acronym for a conference offering deep dives into AD care
  5. 10. Commonly disrupted by night-time itching in patients with AD
  6. 11. Janus kinase inhibitor shown to relieve ad symptoms faster than dupilumab
  7. 12. Poly-l-lysine biovectors were combined with these for AD efficacy
  8. 13. Describes the psychosocial and physical weight of chronic AD
Down
  1. 1. Underlying process targeted by many AD therapies
  2. 3. Clinical term for the hallmark symptom of AD
  3. 5. Topical JAK inhibitor evaluated for use in children aged 2–11
  4. 6. Aryl hydrocarbon receptor agonist with lasting effects in AD
  5. 8. IL-4 receptor blocker commonly used in moderate to severe AD